Study Contributors
COVIDRIVE’s Study Contributors network consists of 29 study sites from 14 different European countries: Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Iceland, Italy, Netherlands, Poland, Romania, Spain and the United Kingdom. Our network includes more than 55 hospitals, 5 primary care networks and a nation-wide register in Finland
COVIDRIVE is open to include new study sites in its European network. For more information on how to join COVIDRIVE, please see section “Participate”
- Centro Interuniversitario per la Ricerca sull’Influenza e le altre Infezioni Trasmissibili (CIRI-IT, Italy)
- COVIREIVAC hospital network, France
- Finnish Institute for Health and Welfare (THL, Finland)
- Fisabio VAHNSI hospital network (Spain)
- Hospital Universitario de Salamanca (Spain)
- Hospital Universitario Germans Trias i Pujol (Spain)
- Hospital Universitario La Paz (Spain)
- Grand Hôpital de Charleroi (Belgium)
- University Hospital Antwerp (UZA, Belgium)
- GZIM GP network (Germany)
- Forum Impfen GP network (Germany)
- Uniklinikum Freiburg (Germany)
- Hospital Universitario Vall d’Hebron and Hospital Universitario Josep Trueta (Spain)
- Iceland Directorate of Health (Iceland)
- Klinik Floridsdorf Vienna (Austria)
- Imperial College London Health Partners (United Kingdom)
- Klinik Favoriten Hospital (Austria)
- LOGEX (Netherlands)
- National Institute for Infectious Diseases, “Prof. Dr. Matei Bals” (Romania)
- National Institute of Public Health (Poland)
- North West E-health (United Kingdom)
- BREATHE consortium (United Kingdom)
- University Hospital Ghent (Belgium)
- CHU Saint Pierre Hospital Brussels (Belgium)
- Hospital Fran Mihaljevic Zagreb (Croatia)
- Universitätsklinikum Frankfurt (Germany)
- Universitätsklinikum Ulm (Germany)
- Universitätsklinikum Köln – DZIF (Germany)
- Aarhus University Hospital (Denmark)
- Odense University Hospital (Denmark)
- Uniklinikum Mainz (Germany)